Renal function during treatment with adefovir plus peginterferon alfa-2a vs either drug alone in hepatitis B/D co-infection
Journal of Viral Hepatitis, 05/15/2012
Mederacke I et al. – Adefovir–containing but not PegIFNα–2a treatment was associated with a decrease in GFR values in about one–fifth of patients. Combination treatment of PegIFNα–2a+ADV in chronic hepatitis B/D co–infection did not lead to any further impairment of kidney function.